Evaluate the Safety and Efficacy of Thrombectomy System in the Intravascular Treatment of Acute Ischemic Stroke

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 202 participants.

Also called NCT05719688

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 202 participants (enrolled count) (from the registry)
Sponsor
Suzhou Hengruihongyuan Medical Technology Co. LTD (from the registry)
Registry
  • NCT NCT05719688
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT05719688. Randomized; no masking; primary purpose treatment. Start 2022-12-16 (actual); primary completion 2023-10-31 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Evaluate the Safety and Efficacy of Thrombectomy System in the Intravascular Treatment of Acute Ischemic Stroke
Condition
Acute Ischemic Stroke
Intervention (Device)
Mechanical thrombectomy
Lead sponsor
Suzhou Hengruihongyuan Medical Technology Co. LTD (class: industry)

Record details

Record id
cardio:ct-nct05719688
Content hash
4e0957961ff703c82f8e2b76a139c5bf6cf320302717c82f43351df4557c5aa7